Journal
eClinicalMedicine
Publication Date
5-1-2023
Volume
59
First Page
101983
Document Type
Open Access Publication
DOI
10.1016/j.eclinm.2023.101983
Rights and Permissions
Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA. SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study. EClinicalMedicine. 2023 May;59:101983. doi: 10.1016/j.eclinm.2023.101983. © 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Hill, Joshua A; Westervelt, Peter; and et al., "SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: A prospective, multicentre, observational study." eClinicalMedicine. 59, 101983 (2023).
https://digitalcommons.wustl.edu/oa_4/2518
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
